Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant vs Primary Chemotherapy With or Without Paclitaxel in Operable Breast Cancer
NCT00003013Phase 3Completed
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Oct 1996
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of paclitaxel in breast cancer, sponsored by Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano. Started Oct 1996; status: completed.
02
Drugs
paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00003013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003013.